Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 17-03-2011 | Practice Area: | Corporate and M&A |
| Deal Title: | Chroma Therapeutics -Cell Therapeutics Licensing Agreement | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Wragge and Co advised biotechnology company Chroma Therapeutics Ltd on a co-development and licensing agreement with biopharmaceutical company Cell Therapeutics Inc. (CTI).
Under the agreement, CTI would make an upfront payment of USD5 million and an additional milestone payment of USD5 million when phase III clinical trials were initiated. Subject to a funding cap of USD50 million over the first three years, CTI would be responsible for 75 per cent of development costs, with Chroma responsible for the remaining 25 per cent.
|
||
| Financial Center: | Birmingham | Value: | 0.00-0.00 |
| Advised Party: | Service Recipient | Law Firm | Gowling WLG |
| Contract Counterparty | United Kingdom | Contract Counterparty | United Kingdom |
| Classification: |
Commercial Contracts and Outsourcing Licensing |
Lawyer | Patrick Duxbury |
